Medicare Advantage contract
H1666 Blue Cross and Blue Shield of NM, TX
Local CCP · Parent: Health Care Service Corporation
⚠ Non-renewal
Latest enrollment
17,302
2025-01
Year-over-year
+17.3%
contract book
National MA share
+0.0%
rank #285 of 936
Overall stars (latest)
★★★ 3.0
summary rating
Enrollment trend · 5 years
Star rating history
| Year | Overall | Part C | Part D | Δ |
|---|---|---|---|---|
| 2020 | ★★★½ 3.5 | 3.5 | 3.5 | — |
| 2021 | ★★★ 3.0 | 3.5 | 3.5 | -0.5 |
| 2022 | ★★★½ 3.5 | 3.5 | 3.5 | +0.5 |
| 2023 | ★★★½ 3.5 | 4.0 | 3.5 | — |
| 2024 | ★★★ 3.0 | 3.0 | 3.0 | -0.5 |
Premium
Median monthly plan premium across this contract's plans, by year.
| Plan | Year | Monthly premium | Part D premium |
|---|---|---|---|
| H1666-003 | 2026 | $96.00 | $92.60 |
| H1666-006 | 2026 | $0.00 | $0.00 |
| H1666-008 | 2026 | $0.00 | $0.00 |
| H1666-012 | 2026 | $0.00 | $0.00 |
| H1666-014 | 2026 | $0.00 | $0.00 |
| H1666-016 | 2026 | $0.00 | $0.00 |
| H1666-019 | 2026 | $59.00 | $0.00 |
| H1666-020 | 2026 | $90.00 | $0.00 |
| H1666-021 | 2026 | $135.00 | $0.00 |
| H1666-022 | 2026 | $142.00 | $63.70 |
| H1666-023 | 2026 | $77.00 | $65.50 |
| H1666-024 | 2026 | $142.00 | $62.20 |
Premium analytics
Deeper cuts for investors and plan-strategy teams, delivered as a custom analysis.
Measure-level star movers
2023 → 2024- C23 Rating of Health Plan 5★ → 1★
- C17 Transitions of Care 4★ → 1★
- C14 Medication Reconciliation Post-Discharge 4★ → 2★
- C18 Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions 4★ → 2★
- D06 Getting Needed Prescription Drugs 3★ → 1★
- C15 Plan All-Cause Readmissions 2★ → 4★
🔒 Want a custom analysis on this? — which measures moved, cut-point sensitivity, and
projected next-year exposure.
Talk to us →
County enrollment
0 counties| State | County | Enrollment |
|---|
Want a custom analysis on this?
Talk to us →County market share vs. competitors
service-area overlapHead-to-head share by county against named competitors, with expansion whitespace and defended turf.
Want a custom analysis on this?
Talk to us →